The Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer Cells

This publication has 36 references indexed in Scilit:

• Questioning the Role of Checkpoint Kinase 2 in the p53 DNA Damage Response
  Published by Elsevier ,2003
• RAF/RAS oncogenes and mismatch-repair status
  Nature, 2002
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
  Nature Genetics, 2002
• The evolution of diverse biological responses to DNA damage: insights from yeast and p53
  Nature Cell Biology, 2001
• Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover
  Biochemical Journal, 2001
• The INK4a/ARF network in tumour suppression
  Nature Reviews Molecular Cell Biology, 2001
• Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway
  Oncogene, 2001
• Reactive Oxygen Species-induced Phosphorylation of p53 on Serine 20 Is Mediated in Part by Polo-like Kinase-3
  Journal of Biological Chemistry, 2001
• Disruption of p53 in human cancer cells alters the responses to therapeutic agents
  Journal of Clinical Investigation, 1999
• Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
  Nature, 1993